Zhi-Fan Li

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Fu Wai Hospital

发表论文 7 篇 · 总被引 43 次 · h-index 3

代表论文

• Remnant Cholesterol and Residual Risk of Atherosclerotic Cardiovascular Disease (2025 · Reviews in Cardiovascular Medicine · 被引 26)
• The Effects of Sacubitril/Valsartan Compared to Olmesartan on the Blood Pressure and Glucolipid Metabolism in DM Patients with Primary Hypertension (2023 · Cardiovascular Drugs and Therapy · 被引 6)
• Effect of changes in the triglyceride-glucose index on atherogenic lipid profiles in coronary artery disease patients receiving lipid-lowering therapy: a prospective cohort study (2025 · Cardiovascular Diabetology · 被引 4)
• Rationale and design of a randomized controlled trial: The effect of intensive lipid-lowering therapy with PCSK9 inhibitor on endothelial-coverage of stent strut after percutaneous coronary intervention (PCI) for patients with acute coronary syndrome (ACS): Optical coherence tomography (OCT) study (PIECES-OCT study) (2023 · Heliyon · 被引 3)
• Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions (2022 · Frontiers in Cardiovascular Medicine · 被引 3)
• The Prognostic Value of Cardiac Troponin I in Patients with or without Three-Vessel Disease Undergoing Complete Percutaneous Coronary Intervention (2022 · Journal of Clinical Medicine · 被引 1)